France

France

Gilead Sciences 65 Quai Georges Gorse 92 100 Boulogne France Phone: +33 1 46 09 41 00 Fax: +33 1 46 09 41 06

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead France is committed to offering and maintaining high-quality service to the medical community and is currently focused on the commercializing of the company's products throughout France.

Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2012, via unrestricted grants. The information is correct at the time of writing (March 2013). The information is subject to change and will be updated accordingly.

• Grant Recipient
  Description of Activity
  Amount Funded €
• SOS HEPATITES
  Core Funding
  75,000
• POSITIFS
  Core Funding
  7,800
• SOL EN SI
  Core funding
  11,000
• ASSOCIATION SYNDROME DE WOLFRAM
  Core funding
  6,000
• ACTUP PARIS
  Core Funding
  50,000
• SIDACTION
  Core Funding
  30,000
• MEDECINS DE L'IMAGINAIRE
  Core funding
  6,500
• LES PETITS BONHEURS
  Core Funding
  15,000
• AIDES
  Core funding
  160,000
• SID'AVENTURE
  Core Funding
  5,000
• DESSINE MOI UN MOUTON
  Core Funding
  15,000
• TRT5
  Core Funding
  20,000
• BASILIADE
  Core Funding
  30,000
• SIDA INFO SERVICE
  Core Funding
  30,000
• ALLIANCE CONTRE LE SIDA
  Core Funding
  13,000
• IKAMBERE
  Core Funding
  15,000
• ACTIONS TRAITEMENTS
  Core Funding
  80,000

Language: Français

This page is intended for visitors outside of the United States.